StoxNarayana Hrudayalaya vs Wockhardt: share price & financials comparison
NSE: NH vs WOCKPHARMA · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Narayana Hrudayalaya vs Wockhardt at a glance
Narayana Hrudayalaya (NH) has a market capitalisation of ₹38,019 Cr, against ₹32,841 Cr for Wockhardt (WOCKPHARMA). Over the past year Wockhardt has returned +48.5%, compared with +1.6% for Narayana Hrudayalaya. On valuation, Narayana Hrudayalaya trades at a lower P/E of 44.3 versus 80.1. Narayana Hrudayalaya earns a higher return on equity (17.2% vs 7.9%). Narayana Hrudayalaya comes out ahead on size and growth. Wockhardt comes out ahead on profitability, financial health and technicals. Across the scored metrics below, Narayana Hrudayalaya leads on 9 and Wockhardt on 8. On StoxGud's 10-point checklist, Narayana Hrudayalaya scores 7/10 and Wockhardt scores 6/10.
| Metric | Narayana Hrudayalaya | Wockhardt |
|---|---|---|
| Size | ||
| Market cap | ₹38,019 Cr | ₹32,841 Cr |
| Revenue (latest FY) | ₹7,896 Cr | ₹3,373 Cr |
| Net profit (latest FY) | ₹806 Cr | ₹213 Cr |
| Valuation | ||
| P/E | 44.3 | 80.1 |
| P/B | 7.60 | 6.37 |
| Dividend yield | 0.24% | — |
| Profitability | ||
| Return on equity | 17.2% | 7.9% |
| Net profit margin | 8.4% | 10.9% |
| Operating margin | 18.5% | 20.4% |
| Growth | ||
| Revenue growth (YoY) | +73.0% | +23.9% |
| Net profit growth (YoY) | +16.5% | +1.3% |
| Revenue CAGR (multi-year) | +25.0% | +4.5% |
| Financial health | ||
| Debt to equity | 0.99 | 0.42 |
| Momentum | ||
| 1-month return | +10.3% | +2.2% |
| 1-year return | +1.6% | +48.5% |
| 3-year CAGR | +19.7% | +92.3% |
| 5-year CAGR | +27.1% | +36.5% |
| 10-year CAGR | +18.9% | +11.2% |
| Distance from 52W high | -10.6% | -13.0% |
| Technicals | ||
| RSI (14) | 76 | 74 |
| Price vs 200-day avg | +1.3% | +17.2% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Narayana Hrudayalaya | Wockhardt |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✓ |
| P/E below industry median | ✓ | ✗ |
| Score | 7/10 | 6/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Narayana Hrudayalaya or Wockhardt?
Narayana Hrudayalaya has a market cap of ₹38,019 Cr and Wockhardt has a market cap of ₹32,841 Cr as of 13 Nov 2026.
Which has a lower P/E, Narayana Hrudayalaya or Wockhardt?
Narayana Hrudayalaya has the lower P/E: Narayana Hrudayalaya trades at 44.3 and Wockhardt at 80.1.
Which gave better returns in the last year, Narayana Hrudayalaya or Wockhardt?
Wockhardt did better: Narayana Hrudayalaya returned +1.6% and Wockhardt returned +48.5% over one year.
What is the difference between Narayana Hrudayalaya and Wockhardt?
Both are NSE-listed companies in Healthcare. Narayana Hrudayalaya is about 1.2 times the size of Wockhardt by market cap. In the latest financial year Narayana Hrudayalaya reported revenue of ₹7,896 Cr and Wockhardt ₹3,373 Cr. Operating margin is 18.5% for Narayana Hrudayalaya and 20.4% for Wockhardt. Debt to equity is 0.99 for Narayana Hrudayalaya and 0.42 for Wockhardt.
Which is better, Narayana Hrudayalaya or Wockhardt?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Narayana Hrudayalaya leads on 9 and Wockhardt on 8. Narayana Hrudayalaya is ahead on size and growth. Wockhardt is ahead on profitability, financial health and technicals. On StoxGud's rules-based checklist Narayana Hrudayalaya scores 7/10 and Wockhardt scores 6/10. This is information, not advice: consult a SEBI-registered adviser before investing.